SEC Comment Letter for Stratos Renewables Corp (SRNW) (CIK 0001321517) — Apr 5, 2022
Stratos Renewables Corp (SRNW) (CIK 0001321517)
Date: April 5, 2022 · CIK: 0001321517 · Accession: 0000000000-22-003640
AI Filing Summary & Sentiment
File numbers found in text: 000-53187
Show Raw Text
United States securities and exchange commission logo
April 5, 2022
George Sharp
President and Director
Stratos Renewables Corp
3535 Executive Terminal Drive
Henderson, NV 89052
Re:Stratos Renewables Corp
Registration Statement on Form 10-12G
Filed March 18, 2022
File No. 000-53187
Dear Mr. Sharp:
We have reviewed your filing and have the following comments. In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have additional comments.
Registration Statement on Form 10-12G filed March 18, 2022
Report of Independent Registered Public Accounting Firm, page F-1
1.Please request BF Borgers CPA PC to provide an appropriately dated report that agrees
with the date included in the consent of March 18, 2022.
Notes to Financial Statements, page F-6
2.Please provide disclosures for the evaluation of subsequent events, including the date
through which subsequent events were evaluated. Refer to ASC 855-10-50 for guidance.
General
3.As noted in our phone conversation on 3/29/2022, it appears that disclosure appearing in
your February 28, 2022 amendment was inadvertently omitted from the most recent
amendment. Please restore the missing disclosure in your next amendment.
FirstName LastNameGeorge Sharp
Comapany NameStratos Renewables Corp
April 5, 2022 Page 2
FirstName LastName
George Sharp
Stratos Renewables Corp
April 5, 2022
Page 2
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
You may contact Tracey Houser at 202-551-3736 or Al Pavot at 202-551-3738 if you
have questions regarding comments on the financial statements and related matters. Please
contact Tyler Howes at 202-551-3370 or Suzanne Hayes at 202-551-3675 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ernest Stern, Esq.